Logo

American Heart Association

  26
  0


Final ID:

A multifaceted family intervention for blood pressure management in rural China: an open label, parallel group, cluster randomized trial (Healthy Family Program)

Abstract Body (Do not enter title and authors here): Background:
Current strategies for blood pressure (BP) control focus primarily on individuals with diagnosed hypertension, yet they have yielded only modest success. Because cardiovascular risk rises continuously with BP, even within the normotensive range, shifting the entire population distribution toward lower levels may prevent more events than targeting high-risk individuals alone. Whether family focused interventions led by trained health instructors can achieve a reduction in BP across populations has not been tested in clinical trials.
Methods:
The Healthy Family Program is a cluster-randomized trial conducted in 80 villages, each comprising 30–50 families. Villages were randomly assigned in a 1:1 ratio to either a family-focused intervention or usual care [ClinicalTrials.gov (NCT06427096)]. All residents aged 40–80 years within participating families were eligible, except those with end-stage diseases or pregnancy plans. The intervention involved training family health instructors in each village and selecting a family leader for every household. Health instructors supervised the family leaders in monitoring BP using a predefined algorithm through a WeChat mini-program, with referral to village doctors for elevated readings. Family health instructors were incentivized based on their performance. Additionally, the program provided free sodium-substitute salt, promoted healthy lifestyle education, supported weight management, and encouraged physical activity. The intervention lasted 6 months, after which study coordination center support, incentives for instructors, and salt distribution were withdrawn. The primary outcome is the change in systolic BP from baseline to 6 months, measured as the absolute difference between the intervention and control groups. Secondary outcomes include the change in systolic BP at 12 months and the difference in diastolic BP between groups at 6 months. The full statistical plan is available at https://www.medrxiv.org/content/10.1101/2025.04.07.25325383v2. Results will be presented at the upcoming conference.
Conclusions:
The outcomes of the Healthy Family Program may provide valuable insights for scaling family focused health initiatives, offering a sustainable approach to improving cardiovascular health in diverse populations. The findings could inform future public health strategies aimed at addressing hypertension, particularly in underserved rural areas.
  • Jiang, Chao  ( Beijing Anzhen Hospital , Beijing , Beijing , China )
  • Dong, Jianzeng  ( Beijing Anzhen Hospital , Beijing , Beijing , China )
  • Cai, Jun  ( Beijing Anzhen Hospital , Beijing , Beijing , China )
  • Anderson, Craig  ( Key Institute of Science and Technology for Brain-inspired Intelligence, Fudan University , Shanghai , China )
  • Du, Xin  ( Beijing Anzhen Hospital , Beijing , Beijing , China )
  • Tang, Yangyang  ( Beijing Anzhen Hospital , Beijing , Beijing , China )
  • Han, Rong  ( Heart Health Research Center , Beijing , Beijing , China )
  • Song, Yanna  ( Ruyang Rural Health Institute , Ruyang , Henan , China )
  • Wang, Chi  ( College of Public Health, University of Iowa , Iowa City , Iowa , United States )
  • Lin, Xiaolei  ( School of Data Science, Fudan University , Shanghai , China )
  • Yi, Yang  ( Heart Health Research Center , Beijing , Beijing , China )
  • Rodgers, Anthony  ( The George Institute for Global Health, University of New South Wales , Camperdown , New South Wales , Australia )
  • Ma, Changsheng  ( Beijing Anzhen Hospital , Beijing , Beijing , China )
  • Author Disclosures:
    Chao Jiang: DO NOT have relevant financial relationships | Jianzeng Dong: No Answer | Jun Cai: DO NOT have relevant financial relationships | Craig Anderson: DO have relevant financial relationships ; Consultant:Auzone BioTech Shanghai:Active (exists now) ; Research Funding (PI or named investigator):Medical Research Council of the UK:Past (completed) ; Research Funding (PI or named investigator):Medical Research Foundation of the UK:Past (completed) ; Research Funding (PI or named investigator):Takeda:Past (completed) ; Consultant:AstraZeneca:Past (completed) ; Research Funding (PI or named investigator):AstraZeneca:Past (completed) ; Research Funding (PI or named investigator):National Health and Medical Research Council (NHMRC) of Australia:Active (exists now) ; Researcher:Fudan University:Active (exists now) ; Employee:The George Institute:Active (exists now) | Xin Du: DO NOT have relevant financial relationships | Yangyang Tang: DO NOT have relevant financial relationships | Rong Han: No Answer | Yanna Song: No Answer | Chi Wang: No Answer | Xiaolei Lin: DO NOT have relevant financial relationships | Yang Yi: No Answer | Anthony RODGERS: DO have relevant financial relationships ; Other (please indicate in the box next to the company name):George Medicines Pty Ltd:Active (exists now) | Changsheng Ma: DO NOT have relevant financial relationships
Meeting Info:

Scientific Sessions 2025

2025

New Orleans, Louisiana

Session Info:

Practice Changing Trials in Blood Pressure Control 

Sunday, 11/09/2025 , 03:30PM - 04:45PM

Late-Breaking Science

More abstracts on this topic:
A major effect of aprocitentan on albuminuria in patients with resistant hypertension

Weber Michael, Bakris George, Flack John, Gimona Alberto, Narkiewicz Krzysztof, Sassi-sayadi Mouna, Wang Jiguang, Schlaich Markus

A Clinical Trial of Healthy Food Subsidies and Behavioral Interventions to Increase Fruit and Vegetable Purchasing in an Online Store

Hua Sophia, Klaiman Tamar, Dixon Erica, Volpp Kevin, Putt Mary, Coratti Samantha, White Jenna, Hossain Mohammad, Posner Hannah, Wang Erkuan, Zhu Jingsan, John Aileen

More abstracts from these authors:
You have to be authorized to contact abstract author. Please, Login
Not Available